Stay updated with breaking news from Project Orbis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration ((FDA)) approved AstraZeneca (AZN) and Daiichi Sankyo's (DSKYF) (DSNKY) Enhertu to treat certain patients with breast cancer.Enhertu...
/PRNewswire/ -- The Bloomberg New Economy International Cancer Coalition (the "Coalition") today called for a permanent paradigm change in the way cancer...
A new consensus paper was published in Nature Medicine by 35 members of Bloomberg New Economy International Cancer Coalition.
The UK’s NICE has recommended Merck’s tepmetko (tepotinib) to treat adult patients with advanced non-small cell lung cancer (NSCLC).
Takeda’s EXKIVITY▼(mobocertinib) granted Conditional Marketing Authorisation in Great Britain · Takeda UK Ltd. is pleased to announce that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation...